AKT1 and cancer: Our findings suggest that brief estrogenic chemical disruption of uterine epithelial cell differentiation, combined with stromal inflammation, promotes abnormal activation of Wnt/β-catenin and PI3K/AKT signaling pathways that drive cancer development.